Sarah McFarlane on Muck Rack

Sarah McFarlane

Verified
  • Chief Energy Transition Correspondent, Reuters
England
As seen in: Reuters, MSN, MSN Ireland, MSN Singapore, UOL, Daily Mail, MSN Malaysia, MSN Money Canada, MSN Philippines, MSN UK, Nature and
Chief energy transition correspondent at Thomson Reuters. Any views expressed are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sarah

Contact Sarah, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A sensitive orange fluorescent calcium ion indicator for imaging neural activity

|
By Abhi Aggarwal, Heather Baker, I-Wen Peter Chen, Carrie Stine, Julia Gonzales, Jonathan S. Marvin, Milene Vandal, Ronak Patel, Frank Visser, Yannick Fouad, Smrithi Sunil, Matthew R. Wiens, Takuya Terai, Kei Takahashi-Yamashiro, Roger Thompson, Timothy Brown, Yusuke Nasu, MINH NGUYEN, Minh Nguyễn, Grant Gordon Verified, Sarah McFarlane Verified, Kaspar Podgorski, Anthony Holtmaat, Robert Campbell, Céline D. Dürst, Pablo de Chambrier, Torgny Lundberg, Cherie A. Brown-Panton, Kenryo Sakoi, Ching-Yao Wang, Alexander W. Lohman
| Nature Verified
Abstract Genetically encoded calcium indicators (GECIs) are vital tools for fluorescence-based visualization of neuronal activity with high spatial and temporal resolution. However, current highest-performance GECIs are predominantly green or red fluorescent, limiting multiplexing options and efficient excitation with fixed-wavelength femtosecond lasers operating at 1030 nm.
Open in Who Shared Issue with article?

Speed Matters: Why RWE Acceleration Starts Upstream with Reusable Data

|
By Sarah McFarlane Verified
| HealthEconomics.com
Written By Amy Sheide, Chief Data Officer, Ontada, and Wes Keller, Head of Product, Ontada Speed in real‑world evidence (RWE) has become easier to demonstrate and harder to defend. Advances in AI have accelerated the extraction of insight from clinical data but have also raised the stakes.
Open in Who Shared Issue with article?

Eli Lilly Pivots to Infectious Disease with Aggressive $3.8B Triple Acquisition

|
By Sarah McFarlane Verified
| HealthEconomics.com
Eli Lilly has made a major strategic pivot back into infectious diseases by executing a trio of biotech acquisitions collectively valued at up to $3.8 billion. Funded by the massive financial success of its GLP-1 weight loss and diabetes portfolio, the drugmaker is acquiring Curevo, LimmaTech Biologics, and Vaccine Company (VaxCo). This aggressive diversification effort signals Lilly’s intent to become a major vaccine innovator, aiming to prevent chronic diseases at their source.
Open in Who Shared Issue with article?
See all 3,112 licensed articles (3,266 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified